awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33810494-62097C4F-CA47-4CF7-9F7F-6498CC8D2795
Q33810494-62097C4F-CA47-4CF7-9F7F-6498CC8D2795
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33810494-62097C4F-CA47-4CF7-9F7F-6498CC8D2795
Phase I study evaluating the combination of lapatinib (a Her2/Neu and EGFR inhibitor) and everolimus (an mTOR inhibitor) in patients with advanced cancers: South West Oncology Group (SWOG) Study S0528.
P2860
Q33810494-62097C4F-CA47-4CF7-9F7F-6498CC8D2795
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33810494-62097C4F-CA47-4CF7-9F7F-6498CC8D2795
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b2f1c6423b41f079e95f65d0c2677a2c525e5780
P2860
Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines.